3,4-dihydroxyphenylacetic acid has been researched along with 2-piperidone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chilmonczyk, Z; Cybulski, M; Duszyńska, B; Dziubina, A; Gołembiowska, K; Iskra-Jopa, J | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylacetic acid and 2-piperidone
Article | Year |
---|---|
In-vivo effects of the 1,2,4-piperazine derivatives MM5 and MC1, putative 5-HT agonists, on dopamine and serotonin release in rat prefrontal cortex.
Topics: 3,4-Dihydroxyphenylacetic Acid; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Dopamine; Extracellular Fluid; Homovanillic Acid; Male; Microdialysis; Piperazines; Piperidones; Poland; Prefrontal Cortex; Pyridines; Radioligand Assay; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Ritanserin; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Agonists; Spiro Compounds; Structure-Activity Relationship | 2005 |